Latest Breaking News On - Hongbo lu - Page 5 : comparemela.com

Arrowhead and Vivo Capital Launch Joint Venture in China to Develop RNAi-Based Therapies

Arrowhead and Vivo Capital Launch Joint Venture in China to Develop RNAi-Based Therapies
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Hong kongHongbo luGaurav aggarwalChristopher anzaloneArrowhead pharmaceuticalsVivo capitalVisirna therapeuticsGreater china

Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital

Press release content from Business Wire. The AP news staff was not involved in its creation.

Hong kongPalo altoUnited statesShan fuJun gaoScott lessneRicky sunDavid liuKatera mujadidiJiaqi zhengHongbo luHepeng shiChina national medical products administrationBain capital life sciencesPearl biotechnology coInvestor group

Vivo Capital, Bain Back Chinese Biotech Firm in $200 Million Fundraising

Chinese biotechnology firm Avistone Pharmaceuticals has raised over $200 million in a series A round led by Vivo Capital in one of the largest such deals for the sector.

United statesHong kongPalo altoHongbo luHepeng shiAvistone pharmaceuticalsZai lab ltdPearl biotechnology coSinovac biotech ltdBolt biotherapeutics incVivo capitalBain capitalPrimavera capitalBeijing based avistonePearl biotechnologyGreater china

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market
tarantobuonasera.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tarantobuonasera.it Daily Mail and Mail on Sunday newspapers.

United statesSan diegoPalo altoNorman tseBenjamin qiuHongbo luAlex qiaoAaron roystonNan fung life sciences pivotalAblaze pharmaceuticalsRayzebio incNan fung groupNan fung life sciencesVivo capitalAdvantech capitalVenture partners china

US-China firm Ablaze Pharma nets $75m co-led by Vivo Capital

The fresh round was jointly led by AdvanTech Capital and Vivo Capital, a Palo Alto-based investment firm that backs the US and China healthcare market.

San diegoUnited statesHong kongHongbo luAlex qiaoAblaze pharmaceuticalsNan fung group life sciencesAdvantech capitalVivo capitalPalo alto basedNan fung groupNan fung life sciencesPivotal bioventure partners chinaBio partnersSamsara biocapitalVenrock healthcare capital